Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Aso

Showing results (401-410 of 434) with videos related to

Pageof 44
Sort By:
Hinyokika Kiyo. Acta Urologica Japonica|December 1, 1988
[Clinical studies on the measurement of urinary tissue polypeptide antigen (TPA) levels using Prolifigen TPA kit "Daiichi"-II in urothelial cancers]H Ohmori, T Ohashi, Y Aso, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|June 1, 1988
[The results of the treatment in renal cell carcinoma]Y Aso, H Masuda, J Hirose, et al.
Hinyokika Kiyo. Acta Urologica Japonica|October 1, 1986
[Treatment of prostatic carcinoma with daily subcutaneous injection of the LH-RH analogue, ICI 118630]M Usami, T Kotake, M Matsuda, et al.
Hinyokika Kiyo. Acta Urologica Japonica|March 1, 1991
[Clinical phase III study on TAP-144-SR, an LH-RH agonist depot formulation, in patients with prostatic cancer]Y Aso, S Kameyama, T Niijima, et al.
Nihon Gan Chiryo Gakkai Shi|May 20, 1988
[Use of VM-26 as a single agent in the treatment of transitional cell carcinoma of the urinary tract]Y Aso, T Ushiyama, K Suzuki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 1, 1986
[Phase II collaborative study of (2''R)-4'-0-tetrahydropyranyladriamycin (THP) for urological malignancies--Urological Co-operative THP Study Group]T Niijima, T Koyanagi, S Sakashita, et al.
Protein Engineering, Design & Selection : PEDS|February 18, 2010
Reduced elimination of IgG antibodies by engineering the variable regionT Igawa, H Tsunoda, T Tachibana, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 1, 1996
Estimate criteria for efficacy of treatment in benign prostatic hyperplasiaY Homma, K Kawabe, T Tsukamoto, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 1, 1997
Preoperative endocrine therapy for clinical stage A2, B, and C prostate cancer: an interim report on short-term effects. Prostate Cancer Study GroupY Homma, H Akaza, K Okada, et al.
Urologic Oncology|January 14, 2011
New treatment approaches for superficial and invasive bladder cancerH B Grossman, F M Debruyne, H Akaza, et al.
Pageof 44

Showing results (401-410 of 434) with videos related to

Sort By:
Pageof 44
Hinyokika Kiyo. Acta Urologica Japonica|December 1, 1988
[Clinical studies on the measurement of urinary tissue polypeptide antigen (TPA) levels using Prolifigen TPA kit "Daiichi"-II in urothelial cancers]H Ohmori, T Ohashi, Y Aso, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|June 1, 1988
[The results of the treatment in renal cell carcinoma]Y Aso, H Masuda, J Hirose, et al.
Hinyokika Kiyo. Acta Urologica Japonica|October 1, 1986
[Treatment of prostatic carcinoma with daily subcutaneous injection of the LH-RH analogue, ICI 118630]M Usami, T Kotake, M Matsuda, et al.
Hinyokika Kiyo. Acta Urologica Japonica|March 1, 1991
[Clinical phase III study on TAP-144-SR, an LH-RH agonist depot formulation, in patients with prostatic cancer]Y Aso, S Kameyama, T Niijima, et al.
Nihon Gan Chiryo Gakkai Shi|May 20, 1988
[Use of VM-26 as a single agent in the treatment of transitional cell carcinoma of the urinary tract]Y Aso, T Ushiyama, K Suzuki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 1, 1986
[Phase II collaborative study of (2''R)-4'-0-tetrahydropyranyladriamycin (THP) for urological malignancies--Urological Co-operative THP Study Group]T Niijima, T Koyanagi, S Sakashita, et al.
Protein Engineering, Design & Selection : PEDS|February 18, 2010
Reduced elimination of IgG antibodies by engineering the variable regionT Igawa, H Tsunoda, T Tachibana, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 1, 1996
Estimate criteria for efficacy of treatment in benign prostatic hyperplasiaY Homma, K Kawabe, T Tsukamoto, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 1, 1997
Preoperative endocrine therapy for clinical stage A2, B, and C prostate cancer: an interim report on short-term effects. Prostate Cancer Study GroupY Homma, H Akaza, K Okada, et al.
Urologic Oncology|January 14, 2011
New treatment approaches for superficial and invasive bladder cancerH B Grossman, F M Debruyne, H Akaza, et al.
Pageof 44